Insider Transactions in Q2 2023 at Generation Bio Co. (GBIO)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 25
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,914
-100.0%
|
$11,656
$4.61 P/Share
|
|
Apr 15
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-29.36%
|
$4,844
$4.5 P/Share
|
|
Apr 15
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+50.0%
|
-
|
|
Apr 15
2023
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-0.97%
|
$8,732
$4.5 P/Share
|
|
Apr 15
2023
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+3.18%
|
-
|
|
Apr 15
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-1.18%
|
$4,844
$4.5 P/Share
|
|
Apr 15
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+3.86%
|
-
|
|
Apr 15
2023
|
Geoff Mcdonough PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,879
-0.54%
|
$27,516
$4.5 P/Share
|
|
Apr 15
2023
|
Geoff Mcdonough PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,437
+1.82%
|
-
|
|
Apr 15
2023
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-7.78%
|
$8,732
$4.5 P/Share
|
|
Apr 15
2023
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+20.95%
|
-
|
|
Apr 15
2023
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-7.78%
|
$8,732
$4.5 P/Share
|
|
Apr 15
2023
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+20.95%
|
-
|
|
Apr 15
2023
|
Douglas Kerr CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-0.61%
|
$8,732
$4.5 P/Share
|
|
Apr 15
2023
|
Douglas Kerr CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+2.03%
|
-
|